ETF Holdings Breakdown of EWTX

News associated with EWTX

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Consensus PT from Brokerages

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers […] - 2025-06-13 05:14:54

Squarepoint Ops LLC Purchases 9,729 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Squarepoint Ops LLC lifted its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,358 shares of the company’s stock after buying an additional 9,729 shares during the quarter. Squarepoint Ops LLC’s […] - 2025-06-03 08:04:51

Two Sigma Investments LP Reduces Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Two Sigma Investments LP lowered its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 49.6% in the 4th quarter, HoldingsChannel reports. The fund owned 131,667 shares of the company’s stock after selling 129,791 shares during the period. Two Sigma Investments LP’s holdings in Edgewise Therapeutics were worth $3,516,000 at the end of the […] - 2025-05-30 08:27:09

Nuveen Asset Management LLC Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Nuveen Asset Management LLC raised its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 428,858 shares of the company’s stock after purchasing an additional 158,452 shares during the quarter. Nuveen Asset Management LLC’s holdings in Edgewise Therapeutics were worth $11,451,000 at […] - 2025-05-28 07:58:59

BNP Paribas Financial Markets Buys Shares of 33,082 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

BNP Paribas Financial Markets purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 33,082 shares of the company’s stock, valued at approximately $883,000. Several other large investors have also recently made changes to their positions in EWTX. First Light Asset Management […] - 2025-05-22 07:38:48

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month […] - 2025-05-16 05:58:59

The Manufacturers Life Insurance Company Has $1.07 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

The Manufacturers Life Insurance Company increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 4.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,170 shares of the company’s stock after purchasing an additional 1,760 shares during the period. The Manufacturers […] - 2025-05-14 07:46:53

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD boosted its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 22.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,050 shares of the company’s stock after purchasing an additional 5,242 shares […] - 2025-05-12 08:18:50

Dimensional Fund Advisors LP Grows Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Dimensional Fund Advisors LP grew its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 729,923 shares of the company’s stock after buying an additional 3,052 shares during […] - 2025-05-08 07:50:47

Envestnet Asset Management Inc. Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Envestnet Asset Management Inc. increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.0% in the 4th quarter, HoldingsChannel reports. The fund owned 14,678 shares of the company’s stock after purchasing an additional 3,561 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Edgewise Therapeutics were worth $392,000 at the end […] - 2025-05-06 07:24:53

Edgewise Therapeutics (NASDAQ:EWTX) Earns Buy Rating from Analysts at Guggenheim

Guggenheim initiated coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $41.00 price target on the stock. Guggenheim’s price target suggests a potential upside of 145.80% from the stock’s current price. Other […] - 2025-05-02 08:02:53

Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Invesco Ltd. lowered its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 43,435 shares of the company’s stock after selling 21,341 shares during the quarter. Invesco Ltd.’s holdings in Edgewise Therapeutics were worth $1,160,000 as of its most recent […] - 2025-05-02 07:26:44

Marshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Marshall Wace LLP reduced its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 94.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,893 shares of the company’s stock after selling 547,672 shares during the period. […] - 2025-05-01 08:43:00

Barclays PLC Has $3.57 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Barclays PLC grew its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 133,657 shares of the company’s stock after purchasing an additional 14,307 shares during the quarter. Barclays PLC’s holdings in Edgewise Therapeutics were worth $3,568,000 at the end of the […] - 2025-04-29 08:08:56

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $40.38 Average PT from Brokerages

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month […] - 2025-04-24 05:10:55

Edgewise Therapeutics (NASDAQ:EWTX) Receives “Outperform” Rating from Wedbush

Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $43.00 price objective on the stock. Wedbush’s price target points to a potential upside of 217.81% from the company’s previous close. Several other research […] - 2025-04-23 06:00:59

Alliancebernstein L.P. Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Alliancebernstein L.P. increased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,260 shares of the company’s stock after purchasing an additional 1,300 shares during the period. Alliancebernstein L.P.’s holdings […] - 2025-04-17 07:30:59

Geode Capital Management LLC Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Geode Capital Management LLC grew its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,600,571 shares of the company’s stock after purchasing an additional 1,036 shares during the quarter. Geode […] - 2025-04-15 08:08:57

Orion Portfolio Solutions LLC Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Orion Portfolio Solutions LLC decreased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 8.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 11,928 shares of the company’s stock after selling 1,083 shares during the period. Orion Portfolio Solutions LLC’s holdings in Edgewise Therapeutics were worth $318,000 at the […] - 2025-04-10 08:38:57

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Acquires $10,000,000.23 in Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) Director Orbimed Advisors Llc acquired 496,771 shares of Edgewise Therapeutics stock in a transaction that occurred on Thursday, April 3rd. The stock was acquired at an average price of $20.13 per share, with a total value of $10,000,000.23. Following the completion of the acquisition, the director now […] - 2025-04-07 09:28:50

Scotiabank Downgrades Edgewise Therapeutics (NASDAQ:EWTX) to Sector Perform

Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) was downgraded by research analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating in a research report issued on Wednesday, Marketbeat.com reports. They currently have a $14.00 target price on the stock, down from their prior target price of $50.00. Scotiabank’s price target would […] - 2025-04-04 06:14:47

Noteworthy Wednesday Option Activity: EWTX, PACK, ORCL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Edgewise Therapeutics Inc (Symbol: EWTX), where a total of 15,988 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to - 2025-04-02 19:27:28

Teacher Retirement System of Texas Has $298,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Teacher Retirement System of Texas raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 18.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,143 shares of the company’s stock after purchasing an […] - 2025-04-02 07:42:47

Quantbot Technologies LP Purchases Shares of 3,855 Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

Quantbot Technologies LP purchased a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 3,855 shares of the company’s stock, valued at approximately $103,000. Other institutional investors have also recently made changes to their positions […] - 2025-04-01 07:54:48

AlphaQuest LLC Reduces Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

AlphaQuest LLC reduced its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 75.6% in the 4th quarter, Holdings Channel reports. The fund owned 2,203 shares of the company’s stock after selling 6,832 shares during the period. AlphaQuest LLC’s holdings in Edgewise Therapeutics were worth $59,000 at the end of the most recent quarter. […] - 2025-03-21 08:06:56

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $41.29 Average Price Target from Brokerages

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […] - 2025-03-05 06:06:48

New York State Common Retirement Fund Increases Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX)

New York State Common Retirement Fund lifted its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 6.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,366 shares of the company’s stock after purchasing an additional […] - 2025-03-03 09:08:32

EWTX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	33,674	USD 439,782
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	21,627	USD 282,449
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	52,476	USD 685,337
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	52,476	USD 685,337
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	908	USD 11,858
Total =		161,161	USD 2,104,763

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer